Send mail to Author

Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer (Article)

Please indicate your contact information and select, which author you want to contact.



 
 _    _     ______    _____    _    _     ______   _    _   
| || | ||  /_   _//  |__  //  | || | ||  /_   _// | || | || 
| || | ||   -| ||-     / //   | || | ||  `-| |,-  | || | || 
| \\_/ ||   _| ||_    / //__  | \\_/ ||    | ||   | \\_/ || 
 \____//   /_____//  /_____||  \____//     |_||    \____//  
  `---`    `-----`   `-----`    `---`      `-`'     `---`
 


Back to frontdoor view

OPUS4 Logo